Fidelio issues call options to Vimian’s Chairman of the Board Magnus Welander

News
Jun 27 2024

Fidelio issues call options to Vimian’s Chairman of the Board Magnus Welander

Vimian Group AB (publ) has been informed that the Company’s largest shareholder Fidelio Vet Holding AB (“Fidelio”) has undertaken to issue 100,000 call options in Vimian to Magnus Welander, Chairman of the Board in Vimian Group AB (publ).

The call options are being issued on market terms and are exercisable into 100,000 shares in Vimian after five years, in three tranches with an exercise price corresponding to SEK 33.16 subject to an annual step-up in exercise price of 5, 10 and 15 percent, respectively, starting on 27 June 2024.

The call options will not dilute the holdings of other shareholders and do not entail any costs for Vimian.

Today, Fidelio owns approximately 297,128,581 shares in Vimian, corresponding to 57% of the shares in Vimian Group AB (publ). Magnus Welander currently owns 73,630 shares in Vimian Group AB (publ).

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 80 markets, has 1,100 employees and annual revenues of approximately EUR 330 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.